Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01154296 · ClinicalTrials.gov registry record · NA

HIV Rapid Testing & Counseling in Sexually Transmitted Disease (STD) Clinics in the U.S.

A NA study, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
5,012
Enrollment target

NCT01154296: Completed NA study, sponsored by Columbia University.

NCT01154296 is a NA study that has completed, run by Columbia University. The registered enrollment target is 5,012 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (257% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01154296, a NA study, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
5,012 participants
Enrollment target

Study Summary

Project Aware is a randomized controlled clinical trial in which individuals seeking medical or health services at sexually transmitted disease (STD) clinics are recruited to participate in a multi-center HIV testing and counseling study. The investigators will assess the relative effectiveness and cost-effectiveness of (1) on-site HIV rapid testing with brief, participant-tailored prevention counseling vs. (2) on-site HIV rapid testing with information only. The investigators will evaluate the effect of counseling on one primary outcome: STI incidence. Secondary outcomes will be reduction of sexual risk behaviors, substance use during sex (i.e., being under the influence during sex) and cost and cost effectiveness of counseling and testing. Participants will be assessed for sexually transmitted infections, HIV testing history and sexual and drug use risk behaviors at baseline and at 6-months follow-up. Approximately 5,000 individuals seeking medical or health services from approximately 9 STD clinics throughout the United States will be randomized. These individuals will be 18 years of age or older and efforts will be made to recruit a sample of study participants that reflects the proportion of minorities and gender in the STD clinic performance sites from which the investigators are recruiting.

Primary Outcome

Composite STI incidence (Yes/No) at 6-month follow-up in which a person is considered positive for STIs if they are positive on any tested STI.

Interventions

  • BEHAVIORAL RESPECT-2 Counseling

Trial Details

FieldValue
Enrollment Target 5,012 participants
Start Date 2010-04
Est. Completion 2012-02
Phase NA
Columbia University

958 total trials

What the finished NCT01154296 record still lists

NCT01154296 is an interventional study that assigns participants to a tested intervention. Its 5,012 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (257% higher).

The record links to 0 conditions, and to 1 intervention - of which RESPECT-2 Counseling is the first listed.

NCT01154296 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01154296 about?

NCT01154296 is a clinical study titled "HIV Rapid Testing & Counseling in Sexually Transmitted Disease (STD) Clinics in the U.S.". Project Aware is a randomized controlled clinical trial in which individuals seeking medical or health services at sexually transmitted disease (STD) clinics are recruited to participate in a multi-center HIV testing and counseling study. The investigators will assess the relative effectiveness and ...

What is the current status of trial NCT01154296?

This trial is currently completed. It is a NA study. The enrollment target is 5,012 participants. The study started on 2010-04. Estimated completion is 2012-02.

What interventions are being tested in trial NCT01154296?

The interventions under investigation include: RESPECT-2 Counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT01154296?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01154296's enrollment target sits among peer trials

5,012 25th of 2000 higher than 1,976 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04743362 · 5,010 participants

    A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions

  • NCT00060541 · 5,000 participants

    Evaluation and Treatment of Neurosurgical Disorders

  • NCT00575081 · 5,000 participants

    Physiological Brain Atlas Development

  • NCT00736749 · 5,000 participants

    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01154296, the US trial registry maintained by the National Library of Medicine. NCT01154296 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.